Opyl
Healthcare Software · Australia · 1-10 Employees
View Company Info for Free
Overview
Headquarters
L 10 99 Queen St, Melbourne, Victoria, 3...Website
www.opyl.aiRevenue
<$5 MillionStock Symbol
OPLIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Opyl
Opyl is an Australian digital health company that leverages artificial intelligence to enhance clinical trial design and predict outcomes. Its AI-powered platform, TrialKey, utilizes extensive data from over 468,429 trials to provide actionable insights for researchers, biopharmaceutical firms, and medical investors. The company aims to optimize trial design and improve delivery while addressing the challenges posed by high failure rates in clinical trials. Ultimately, Opyl seeks to set a leading benchmark in AI-driven clinical trial optimization worldwide.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Opyl your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Opyl
Opyl, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Opyl has new funding data
Earning: See what the market has to say on Opyl recently announced quarterly report
Click to see if Opyl had a recent Job posting/layoffs
Product Launch: Get notified when Opyl launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Opyl is spiking on competitors!
Check if Opyl has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Opyl
Compare insights from companies similar to Opyl, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Opyl
<$5M
1-10
Public
-
2013
N/A
Company Profile Activity
Activity Insights
Opyl is experiencing very low activity levels compared to other companies in the Software sector.
What does this means?
Opyl is drawing exceptional interest within the Software industry, suggesting notable developments or strong market momentum, learn more about Opyl.
Opyl Tech Stack
A closer look at the technologies used by Opyl
Opyl News & Media
Opyl Limited Appoints Matt Hallam as Chief Revenue Officer to Boost TrialKey.ai Growth
Opyl Ltd. ( ($AU:OPL) ) has provided an update. Opyl Limited has appointed Matt Hallam as Chief Revenue Officer to enhance the commercial growth of its core product...Pleasing Signs As A Number Of Insiders Buy Opyl Stock
When a single insider purchases stock, it is typically not a major deal. However, when multiple insiders purchase...Multiple insiders bought Opyl Limited (ASX:OPL) stock earlier this year, a positive sign for shareholders
Generally, when a single insider buys stock, it is usually not a big deal. However, when several insiders are buying...Tech firms 'shocked' at Canberra's export grant cuts - AFR
Austrade is citing overwhelming demand in cutting as much as 77 per cent from export grants promised by the Morrison government.
Read more news
Top Healthcare Software Companies
Top companies in Canada by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Opyl
Sign Up For FreeTo access detailed company insights
Opyl is an Australian digital health company that leverages artificial intelligence to enhance clinical trial design and predict outcomes. Its AI-powered platform, TrialKey, utilizes extensive data from over 468,429 trials to provide actionable insights for researchers, biopharmaceutical firms, and medical investors. The company aims to optimize tr... Read More
